Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: Sept. 13, 2021

Here are some of HealthDay's top stories for Monday, Sept. 13: Unvaccinated have 11 times the odds of dying from COVID-19. A series of three studies published...

ADHD Linked to Alzheimer Disease Across Generations

MONDAY, Sept. 13, 2021 -- There is an association for attention-deficit/hyperactivity disorder (ADHD) with Alzheimer disease (AD) and any dementia across...

Extended Anticoagulation Tied to Major Bleeding Risk

MONDAY, Sept. 13, 2021 -- The long-term risks and consequences of anticoagulant-related major bleeding are considerable among patients receiving extended oral...

American Academy of Orthopaedic Surgeons, Aug. 31-Sept. 3

The annual meeting of the American Academy of Orthopaedic Surgeons was held from Aug. 31 to Sept. 3 in San Diego and attracted approximately 5,000 participants...

COVAX Cuts Global COVID-19 Vaccine Supply Estimates by a Quarter

MONDAY, Sept. 13, 2021 -- Fewer COVID-19 vaccine doses than expected will be available through the global COVAX program, affecting many less-affluent nations...

Appeals Court Backs Florida Ban on School Mask Mandates

MONDAY, Sept. 13, 2021 -- The law on whether or not students in Florida schools will be required to wear masks has changed again. On Friday, the First District...

Are Stillbirths More Common in Women Infected With COVID?

MONDAY, Sept. 13, 2021 -- COVID-19 is surging in U.S. states with low vaccination rates, and these places may also be seeing a higher-than-usual number of...

Data Doesn't Support Need for COVID-19 Vaccine Boosters: Experts

MONDAY, Sept. 13, 2021 -- COVID-19 vaccine booster shots might not be needed for most people, according to a large international review. The review --...

9/11 First Responders Face Higher Cancer Risk 20 Years Later

MONDAY, Sept. 13, 2021 -- Twenty years on, responders to the World Trade Center attacks in New York City are showing increased risks of certain cancers, two...

Obamacare's Medicaid Expansion Helped Americans' Blood Pressure

MONDAY, Sept. 13, 2021 -- With the expansion of Medicaid under Obamacare, fewer Americans are uninsured and more are getting their blood pressure and blood...

FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine

SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative...

FDA Acceptance for Filing of New Drug Application (NDA) for Trientine Tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease

NDA supported by positive data from Phase 3 CHELATE clinical trial TETA 4-HCl previously granted Orphan Drug Designation for first-line treatment of...

FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia

TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration...

Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma

SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX...

U.S. FDA Grants Brukinsa (zanubrutinib) Approval in Waldenström’s Macroglobulinemia

CAMBRIDGE, Mass. & BEIJING, September 01, 2021--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on...

UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older

ATLANTA, Aug. 30, 2021 /PRNewswire/ -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact...

Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine

Final blinded analysis of Phase 3 COVE study of the Moderna COVID-19 vaccine shows 93% efficacy; efficacy remains durable through six months after second...

Servier Announces FDA Approval of Tibsovo (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma

Tibsovo is the first and only targeted therapy approved for patients with previously treated IDH1-mutated cholangiocarcinoma BOSTON, Aug. 25, 2021...

Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of Comirnaty in Individuals 16 and Older

New Phase 3 data show booster (third) dose of Comirnaty induces significant SARS-CoV-2 neutralizing antibody titers and demonstrated a favorable safety and...

Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome

BOSTON, Aug. 24, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery...

Emalex Biosciences Recruiting People Who Stutter for Phase 2 Clinical Trial for Childhood-Onset Fluency Disorder

CHICAGO, Sept. 14, 2021. Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical company focused on developing treatments for central nervous system movement...

UKLS Trial Meta-Analysis Confirms that Low Dose CT Screening for Lung Cancer Reduces Mortality

DENVER, Sept. 13, 2021-- Low-dose CT lung cancer (LDCT) screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared...

New Columbia-Pfizer Clinical Trials Diversity Initiative aims to reduce health disparities

10 September 2021. Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the...

Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet

NORTH CHICAGO, Ill., and COPENHAGEN, Denmark, Sept, 9, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced The Lancet...

Dermavant Announces First Patient Dosed in ADORING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Atopic Dermatitis

LONG BEACH, Calif., and BASEL, Switzerland, September 9, 2021—Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.